What Dermatologists Should Know About Approaching Alopecia Patients
Next Steps in Derm, in partnership with Skin of Color Update, interviewed dermatologist Dr. Victoria Barbosa, associate professor at University of Chicago Medicine. Watch as Dr. Barbosa shares why it may be challenging for an alopecia patient to visit a dermatologist and why it’s important to address the psychological burden of hair loss. Hear how considering a broad differential is essential t …
Next Steps in Derm, in partnership with Skin of Color Update, interviewed dermatologist Dr. Victoria Barbosa, associate professor at University of Chicago Medicine. Watch as Dr. Barbosa shares why it may be challenging for an alopecia patient to visit a dermatologist and why it’s important to address the psychological burden of hair loss. Hear how considering a broad differential is essential t … Continue reading "What Dermatologists Should Know About Approaching Alopecia Patients"
Stylecaster recently posted an online article about psychodermatology. How do the mind and skin influence each other? What do we now know and what questions are still unanswered? How can dermatology clinicians best counsel their patients when the mind-skin connection is at work?
For expert advice, I reached out to Steven Daveluy, MD, FAAD, associate professor and program director at Wayne St … 
Bimekizumab (Bimzelx®) is a new injectable medication FDA approved for plaque psoriasis. It is the first and only FDA approved IL-17A and IL-17F inhibitor for this disease, but is also being used as an off-label option for other conditions including psoriatic arthritis and hidradenitis suppurativa. This Therapeutic Cheat Sheet will focus on the on and off label uses of bimekizumab.
Bimekizuma … 
Media attention about oral minoxidil has impacted access to the hair loss drug in the Washington, D.C. area, according to a study published in the January issue of the Journal of Drugs in Dermatology. Researchers found shortages of the drug in D.C.-area pharmacies more than a year after an article about the treatment appeared in The New York Times.
To find out more about oral minoxidil access, … 
Pretibial myxedema (PTM) is a rare complication of Graves' disease. It is characterized by non-pitting edema with hyperpigmented hyperkeratotic papules and plaques on bilateral lower legs. Effective treatments for patients with PTM are lacking. The etiology of PTM is unknown; however, it may be similar to the mechanism of thyroid-associated ophthalmopathy (TAO). Activated fibroblasts produce infla … 